Intended for healthcare professionals


ADHD: GPs are told to review some patients amid drug shortages

BMJ 2023; 382 doi: (Published 28 September 2023) Cite this as: BMJ 2023;382:p2250
  1. Elisabeth Mahase
  1. The BMJ

GPs have been advised not to start new patients on several drugs for treating attention deficit/hyperactivity disorder that are in short supply in the UK, said the Department of Health and Social Care, because of a combination of manufacturing problems and increasing global demand.

Drugs affected by the disruption, which is expected to last until the end …

View Full Text

Log in

Log in through your institution


* For online subscription